One of my papers on using a new device to concentrate bone marrow that does not need centrifugation...this is huge https://t.co/ONIlwtvcrK
Happy to have published with international colleagues on a novel way of extracting bone marrow #stemcells without the need to centrifuge https://t.co/ONIlwtvcrK
Paper I published discussing a new way of purifying bone marrow concentrated without having to spin the cells !! https://t.co/ONIlwte9pK
Paper I authored on a new way to extract #stemcells without need for centrifugation https://t.co/ONIlwtvcrK
RT @mattmchale84: $CELZ @CaverStem https://t.co/hNKmJf5Fci
From The Journal of Translational Medicine in January 2019 coauthored by Dr. Amit Patel and Dr. Thomas Ichim. …https://t.co/9TacO6mAmX … @CaverStem @femcelz @usnews @nytimes @USATODAY @washingtonpost @TheDoctors @NewYorker @MiamiHerald @chicagohealth #ere
RT @MdFacep: A paper on the FDA approved Generation 2 bone marrow harvest technology was published in The Journal of Translational Medicine…
RT @MdFacep: A paper on the FDA approved Generation 2 bone marrow harvest technology was published in The Journal of Translational Medicine…
RT @MdFacep: A paper on the FDA approved Generation 2 bone marrow harvest technology was published in The Journal of Translational Medicine…
RT @MdFacep: A paper on the FDA approved Generation 2 bone marrow harvest technology was published in The Journal of Translational Medicine…
A paper on the FDA approved Generation 2 bone marrow harvest technology was published in The Journal of Translational Medicine in January 2019 coauthored by Dr. Amit Patel and Dr. Thomas Ichim. @CaverStem @DoctorAmitPatel @GershmanMDLA @antoniniurology
RT @mattmchale84: $CELZ https://t.co/rcCbW7y4hF
RT @DreamWeaver2018: $CELZ Patents making progress https://t.co/Se1SCGGY57
RT @DreamWeaver2018: $CELZ Patents making progress https://t.co/Se1SCGGY57
RT @DreamWeaver2018: $CELZ Patents making progress https://t.co/Se1SCGGY57
RT @MdFacep: A paper on the FDA approved Generation 2 bone marrow harvest technology was published in The Journal of Translational Medicine…
RT @DreamWeaver2018: $CELZ Patents making progress https://t.co/Se1SCGGY57
A paper on the FDA approved Generation 2 bone marrow harvest technology was published in The Journal of Translational Medicine in January 2019 coauthored by Dr. Amit Patel and Dr. Thomas Ichim. https://t.co/9TacO6mAmX https://t.co/dmt3vGMLz8
RT @hainesly1111: $CELZ Shareholders update out. https://t.co/KH2CMgpIe3 Mentions publishing of an article in FDA approved Generation 2 b…
RT @hainesly1111: $CELZ Shareholders update out. https://t.co/KH2CMgpIe3 Mentions publishing of an article in FDA approved Generation 2 b…
RT @hainesly1111: $CELZ Shareholders update out. https://t.co/KH2CMgpIe3 Mentions publishing of an article in FDA approved Generation 2 b…
RT @hainesly1111: $CELZ Shareholders update out. https://t.co/KH2CMgpIe3 Mentions publishing of an article in FDA approved Generation 2 b…
RT @hainesly1111: $CELZ Shareholders update out. https://t.co/KH2CMgpIe3 Mentions publishing of an article in FDA approved Generation 2 b…
$CELZ Shareholders update out. https://t.co/KH2CMgpIe3 Mentions publishing of an article in FDA approved Generation 2 bone marrow harvesting technology. https://t.co/n2mOQTlY3M https://t.co/0717Z7QGsT
RT @MdFacep: some of the forecast news is this: https://t.co/9TacO6mAmX @CaverStem https://t.co/RYxrTpV1ax
some of the forecast news is this: https://t.co/9TacO6mAmX @CaverStem
Research Open Access Isolation of clinically relevant concentrations of bone marrow mesenchymal stem cells without centrifugation Michael ScarponeEmail author, Daniel KueblerEmail authorView... https://t.co/ZsudOlP3Cx
@CaverStem
Isolation of clinically relevant concentrations of bone marrow mesenchymal stem… https://t.co/RPcgy12fRw #JTransMed